BostonGene and Exigent Genomic INsight Study
NCT06272864
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Breast Cancer
- Non-small Cell Lung Cancer
- Melanoma
- Sarcoma
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- BostonGene
- Last updated on ClinicalTrials.gov
- February 17, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 1
- Highlands Oncology Group · Rogers, AR
California · 1
- Stockton Hematology Oncology Medical Group · Stockton, CA
Indiana · 1
- Fort Wayne Medical Oncology and Hematology · Fort Wayne, IN
New Mexico · 1
- New Mexico Cancer Center · Albuquerque, NM
Oklahoma · 1
- Oklahoma Cancer Specialists and Research Institute · Tulsa, OK
Texas · 1
- Oncology Consultants · Houston, TX
Washington · 1
- Northwest Medical Specialities · Puyallup, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.